Document Detail

Prognostic parameters in myelodysplastic syndromes: a multiple regression analysis.
MedLine Citation:
PMID:  3345829     Owner:  NLM     Status:  MEDLINE    
The influence on survival of 21 basic clinical and hematologic parameters was evaluated in 72 patients with previously untreated myelodysplastic syndromes (MDS). Only five parameters were significant by both survival curves and multiple regression analyses: hemoglobin level, bone marrow (BM) cellularity (estimated from trephine BM biopsies), BM blast percentage, age and BM erythro/myeloid (E/M) ratio. Using these parameters, multiple regression analysis enabled us to predict 34% of the survival of all MDS patients (p less than 0.002), 38% of that of patients who had stable disease (p less than 0.04) and over 80% of that of patients who developed acute leukemia (p less than 0.02). High BM cellularity was the most predictive factor for the development of leukemia. No factor was predictive for patients who died of cytopenic or other complications.
A Riccardi; M Giordano; P Giordano; E Cassano; M Girino; M Cazzola; P Scivetti; M Danova; G Ucci
Related Documents :
1382719 - Genomic hypomethylation in human chronic lymphocytic leukemia.
6849839 - Coexistent myelodysplasia and plasma cell neoplasia.
10764149 - Cytogenetic analogy between myelodysplastic syndrome and acute myeloid leukemia of elde...
6897059 - Lymphoblastic lymphoma: cytogenetic, pathologic, and immunologic studies.
15201999 - Prognostic significance of additional cytogenetic abnormalities in newly diagnosed pati...
3477869 - Old age: a sign of poor prognosis in patients with chronic myelogenous leukemia.
24945819 - Obscure recurrent gastrointestinal bleeding: a revealed mystery?
6691939 - Pulmonary granulomatous reaction: talc pneumoconiosis or chronic sarcoidosis?
24211319 - Prediction of poor mobilization of autologous cd34+ cells with growth factor in multipl...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  European journal of haematology     Volume:  40     ISSN:  0902-4441     ISO Abbreviation:  Eur. J. Haematol.     Publication Date:  1988 Feb 
Date Detail:
Created Date:  1988-04-15     Completed Date:  1988-04-15     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8703985     Medline TA:  Eur J Haematol     Country:  DENMARK    
Other Details:
Languages:  eng     Pagination:  158-62     Citation Subset:  IM    
Istituto di Clinica Medica II, Dipartimento di Medicina Interna e Terapia Medica, Matteo, Pavia, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Myelodysplastic Syndromes / blood,  mortality,  physiopathology*
Regression Analysis
Time Factors

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Unexplained lymphadenopathy in sickle cell disease.
Next Document:  M-2 protocol for melphalan-resistant and relapsing multiple myeloma.